Borosil Scienti.

  • Market Cap: Micro Cap
  • Industry: Industrial Products
  • ISIN: INE02L001032
  • NSEID: BOROSCI
  • BSEID: 544184
INR
126.85
3.55 (2.88%)
BSENSE

Sep 01, 03:30 PM

BSE+NSE Vol: 99.69 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

99.69 k (86.44%) Volume

Shareholding (Jun 2026)

FII

0.23%

Held by 5 FIIs

DII

0.27%

Held by 0 DIIs

Promoter

68.27%

Why is Borosil Scientific Ltd falling/rising?

02-Sep-2026

As of 01-Sep, Borosil Scientific Ltd's stock price is rising to 126.85, reflecting a 2.88% increase after a trend reversal. Despite a 19.66% decline over the past month, the company remains financially strong, being net-debt free and showing an 83.7% profit increase year-over-year.

As of 01-Sep, Borosil Scientific Ltd's stock price is rising, currently at 126.85, with a change of 3.55 (2.88%) upward. This increase can be attributed to several factors. Notably, the stock has outperformed the sector by 2.19% today and has experienced a trend reversal after three consecutive days of decline. Additionally, the stock reached an intraday high of Rs 129, reflecting a gain of 4.62%.<BR><BR>Despite a significant decline of 19.66% over the past month, the company's financial health remains strong, being net-debt free and showing a remarkable profit increase of 83.7% over the past year. The stock is trading at a fair valuation compared to its peers, with a Price to Book Value of 2.5 and a PEG ratio of 0.3. However, it is important to note that investor participation has decreased, with delivery volume falling by 13.89% against the 5-day average, which may indicate a cautious sentiment among investors. Overall, the combination of today's performance and the company's solid financial metrics contributes to the current rise in the stock price.

View full answer

What does Borosil Scienti. do?

01-Sep-2026

Borosil Scientific Ltd is a micro-cap company in the industrial products sector, reporting net sales of 107 Cr and a net profit of 4 Cr for June 2026. Key metrics include a P/E ratio of 25.00 and a market cap of INR 1,105 Cr.

Overview: <BR>Borosil Scientific Ltd operates in the industrial products sector and is categorized as a micro-cap company.<BR><BR>History: <BR>The company was originally incorporated in 1991 under the name 'Klass Pack Private Limited'. The latest quarterly results reported are for June 2026, showing net sales and profit figures.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 107 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 4 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 1,105 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 25.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.29 <BR>Return on Equity: 9.64% <BR>Price-to-Book: 2.50 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

View full answer

Who are the peers of the Borosil Scienti.?

01-Sep-2026

Borosil Scienti.'s peers include Tinna Rubber, Wendt India, Belding India, Shree Refrigerat, GRP, Sejal Glass, JTL Defence, L. T. Elevator, and Cryogenic OGS. Borosil Scienti. has below-average management and growth risks, an excellent capital structure, and a 1-year return of -10.36%.

Peers: The peers of Borosil Scienti. are Tinna Rubber, Wendt India, Belding India, Shree Refrigerat, GRP, Sejal Glass, JTL Defence, L. T. Elevator, and Cryogenic OGS.<BR><BR>Quality Snapshot: Excellent management risk is observed at Tinna Rubber, L. T. Elevator, and Cryogenic OGS, while Good management risk is found at Wendt India and Shree Refrigerat. Below Average management risk is present at Belding India, Borosil Scienti., GRP, Sejal Glass, and JTL Defence. Growth is Excellent at Shree Refrigerat and Sejal Glass, while Average growth is noted at Tinna Rubber, L. T. Elevator, and Cryogenic OGS. Below Average growth is seen at Wendt India, Belding India, Borosil Scienti., GRP, JTL Defence, and the rest. Excellent capital structure is found at Borosil Scienti., L. T. Elevator, and Cryogenic OGS, while Average capital structure is noted at Shree Refrigerat and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Cryogenic OGS at 219.92%, while the lowest is Belding India with N/A, and Borosil Scienti.'s 1-year return is -10.36%. Additionally, GRP and JTL Defence have negative six-month returns.

View full answer

How big is Borosil Scienti.?

01-Sep-2026

As of 31st August, Borosil Scientific Ltd has a market capitalization of 1,105.00 Cr, with net sales of 478.12 Cr and a net profit of 43.15 Cr over the latest four quarters.

As of 31st August, <BR><BR>Market Cap: Borosil Scientific Ltd has a market capitalization of 1,105.00 Cr, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 478.12 Cr, while the sum of Net Profit for the same period is 43.15 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2025. Shareholder's Funds amount to 404.39 Cr, and Total Assets are valued at 504.34 Cr.

View full answer

Which are the latest news on Borosil Scienti.?

01-Sep-2026

Should I buy, sell or hold Borosil Scientific Ltd?

01-Sep-2026

Are Borosil Scientific Ltd latest results good or bad?

04-Aug-2026

Borosil Scientific Ltd's latest results are concerning, showing an 11.22% year-on-year revenue growth but a 25.44% sequential decline in net sales, leading to an 83.94% drop in net profit and a significant decrease in operating margins. Overall, the financial performance indicates serious operational challenges, characterizing the results as bad.

Borosil Scientific Ltd's latest results for Q1 FY27 indicate a challenging financial performance. While the company achieved a year-on-year revenue growth of 11.22%, it experienced a significant sequential decline in net sales by 25.44% compared to the previous quarter. This drop in revenue is concerning, particularly as it reflects operational challenges that have led to severe margin compression.<BR><BR>The net profit for the quarter plummeted by 83.94% quarter-on-quarter, falling to ₹4.37 crore. Additionally, the operating margin decreased dramatically from 22.43% in the previous quarter to just 7.93%, indicating serious issues with cost management and profitability. The profit before tax also saw a sharp decline, which has understandably shaken investor confidence.<BR><BR>Overall, while the revenue growth on a year-on-year basis is a positive sign, the drastic declines in profit and margins suggest that the company's current financial health is under significant strain. Therefore, the latest results can be characterized as bad, reflecting deeper operational challenges that need to be addressed for a recovery.

View full answer

When is the next results date for Borosil Scientific Ltd?

28-Jul-2026

The next results date for Borosil Scientific Ltd is August 3, 2026.

The next results date for Borosil Scientific Ltd is scheduled for August 3, 2026.

View full answer

Is Borosil Scienti. technically bullish or bearish?

03-Dec-2025

As of December 2, 2025, the technical trend has shifted to a bearish stance with moderate strength, supported by bearish MACD, moving averages, and Bollinger Bands, despite a mildly bullish OBV signal.

As of 2 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and the daily moving averages also indicate a bearish trend. The Bollinger Bands on the weekly chart confirm this bearish outlook. Although the On-Balance Volume (OBV) shows a mildly bullish signal on the weekly timeframe, it is countered by the overall bearish indicators. The stock has underperformed significantly compared to the Sensex over multiple time frames, further supporting the bearish sentiment.

View full answer

How has been the historical performance of Borosil Scienti.?

24-Nov-2025

Borosil Scienti. showed positive financial growth from March 2024 to March 2025, with net sales increasing to 438.49 Cr, profit after tax rising to 26.72 Cr, and significant improvement in cash flow from operating activities to 120.00 Cr. Key metrics like earnings per share and operating profit margin also saw increases, indicating solid overall performance.

Answer:<BR>The historical performance of Borosil Scienti. shows a positive trend in key financial metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>Borosil Scienti. reported net sales of 438.49 Cr in March 2025, an increase from 395.98 Cr in March 2024. The total operating income also rose to 438.49 Cr from 395.98 Cr, with raw material costs increasing to 143.54 Cr from 128.47 Cr, while the purchase of finished goods decreased slightly. Total expenditure, excluding depreciation, grew to 385.90 Cr from 349.30 Cr, leading to an operating profit (PBDIT) of 60.41 Cr, up from 50.70 Cr. Profit before tax improved to 40.39 Cr from 31.55 Cr, resulting in a profit after tax of 26.72 Cr compared to 23.48 Cr the previous year. The earnings per share increased to 3.01 from 2.65, and the operating profit margin rose to 11.99% from 11.79%. On the balance sheet, total liabilities increased to 504.34 Cr from 488.31 Cr, while total assets also grew to 504.34 Cr from 488.31 Cr. Cash flow from operating activities significantly improved to 120.00 Cr from 30.00 Cr, indicating a stronger cash position. Overall, Borosil Scienti. demonstrated growth in sales, profits, and cash flow, reflecting a solid financial performance over the year.

View full answer

Is Borosil Scienti. overvalued or undervalued?

19-Nov-2025

As of November 18, 2025, Borosil Scientific is considered overvalued with a PE ratio of 65.87 and has underperformed the Sensex, indicating it may be expensive compared to its peers despite being relatively more attractive than Borosil Renewables.

As of 18 November 2025, Borosil Scientific has moved from a fair to an expensive valuation grade. The company is currently considered overvalued, with a PE ratio of 65.87, an EV to EBITDA ratio of 27.83, and a Price to Book Value of 2.98. These ratios indicate that the stock is trading at a premium compared to its earnings and book value, suggesting a lack of justification for its current price level.<BR><BR>In comparison to its peers, Borosil Scientific's valuation appears high, especially when looking at Asahi India Glass, which has a PE ratio of 88, and Borosil Renewables, with a staggering PE of 216.85. While Borosil itself is categorized as expensive, it is relatively more attractive than its direct competitors like Borosil Renewables. Recent stock performance shows that Borosil has underperformed the Sensex over the past year, with a return of -22.18% compared to the Sensex's 9.48%, further reinforcing the notion that the stock may be overvalued at its current price of 135.60.

View full answer

Who are the top shareholders of the Borosil Scienti.?

06-Jun-2025

The top shareholder of Borosil Scienti is Kiran Kheruka, with a 25.53% stake. Promoters hold the majority of shares, while the highest public shareholder is the Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account at 2.23%.

The top shareholders of Borosil Scienti include Kiran Kheruka, who holds the highest promoter stake at 25.53%. The majority of the shares are held by promoters, with no pledged promoter holdings reported. Additionally, the highest public shareholder is the Borosil Scientific Limited Unclaimed Securities Suspense Escrow Account, which holds 2.23%. Individual investors collectively own 22.88% of the shares, while mutual funds and foreign institutional investors hold minor stakes of 0.01% and 0.24%, respectively.

View full answer

Has Borosil Scienti. declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor Management Efficiency with a low ROE of 8.13%

  • The company has been able to generate a Return on Equity (avg) of 8.13% signifying low profitability per unit of shareholders funds
2

The company is Net-Debt Free

 
3

Poor long term growth as Net Sales has grown by an annual rate of 7.78% and Operating profit at 19.91% over the last 5 years

 
4

Flat results in Jun 26

5

With ROE of 9.6, it has a Fair valuation with a 2.5 Price to Book Value

6

Despite the size of the company, domestic mutual funds hold only 0.04% of the company

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Industrial Products

stock-summary
Market cap

INR 1,120 Cr (Micro Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.29

stock-summary
Return on Equity

9.64%

stock-summary
Price to Book

2.50

Revenue and Profits:
Net Sales:
107 Cr
(Quarterly Results - Jun 2026)
Net Profit:
4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.08%
0%
-16.08%
6 Months
22.92%
0%
22.92%
1 Year
-8.01%
0%
-8.01%
2 Years
-36.56%
0%
-36.56%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Borosil Scienti. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

35Th Annual General Meeting Of The Company.

28-Aug-2026 | Source : BSE

35th Annual General Meeting of the Company is scheduled to be held on Friday September 25 2026 at 11:00 a.m. through VC/OAVM.

Announcement under Regulation 30 (LODR)-Newspaper Publication

28-Aug-2026 | Source : BSE

Newspaper Advertisements- Information regarding the 35th Annual General Meeting of the Members of the Company.

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

13-Aug-2026 | Source : BSE

Intimation of allotment of 4475 equity shares against stock options exercised under the Companys ESOP Scheme

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
7.78%
EBIT Growth (5y)
19.91%
EBIT to Interest (avg)
26.32
Debt to EBITDA (avg)
0.27
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
1.03
Tax Ratio
18.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.50%
ROCE (avg)
9.84%
ROE (avg)
8.13%

Valuation key factors

Factor
Value
P/E Ratio
25
Industry P/E
34
Price to Book Value
2.54
EV to EBIT
21.36
EV to EBITDA
15.11
EV to Capital Employed
3.17
EV to Sales
2.08
PEG Ratio
0.30
Dividend Yield
NA
ROCE (Latest)
13.69%
ROE (Latest)
9.64%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.01%)

FIIs

Held by 5 FIIs (0.23%)

Promoter with highest holding

Kiran Kheruka (25.52%)

Highest Public shareholder

Investor Education And Protection Fund Authority Ministry Of Corporate Affairs (2.21%)

Individual Investors Holdings

22.5%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -25.44% vs 18.03% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -83.94% vs 213.48% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "106.75",
          "val2": "143.17",
          "chgp": "-25.44%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.46",
          "val2": "32.11",
          "chgp": "-73.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.25",
          "val2": "0.26",
          "chgp": "-3.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.37",
          "val2": "27.21",
          "chgp": "-83.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.93%",
          "val2": "22.43%",
          "chgp": "-14.50%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -1.90% vs 15.21% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -109.18% vs 62.32% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "202.88",
          "val2": "206.81",
          "chgp": "-1.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.90",
          "val2": "25.27",
          "chgp": "-48.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.61",
          "val2": "0.75",
          "chgp": "-18.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.61",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.27",
          "val2": "13.83",
          "chgp": "-109.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.36%",
          "val2": "12.22%",
          "chgp": "-5.86%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 5.16% vs 10.41% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -59.13% vs 27.14% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "324.18",
          "val2": "308.26",
          "chgp": "5.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.09",
          "val2": "35.28",
          "chgp": "-14.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.87",
          "val2": "1.10",
          "chgp": "-20.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.53",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.41",
          "val2": "18.13",
          "chgp": "-59.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.28%",
          "val2": "11.44%",
          "chgp": "-2.16%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 6.58% vs 10.74% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 29.14% vs 13.75% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "467.34",
          "val2": "438.49",
          "chgp": "6.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "62.19",
          "val2": "52.59",
          "chgp": "18.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.13",
          "val2": "1.55",
          "chgp": "-27.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.53",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "34.61",
          "val2": "26.80",
          "chgp": "29.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.31%",
          "val2": "11.99%",
          "chgp": "1.32%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQstock-summary

Jun'26
Mar'26
Change(%)
Net Sales
106.75
143.17
-25.44%
Operating Profit (PBDIT) excl Other Income
8.46
32.11
-73.65%
Interest
0.25
0.26
-3.85%
Exceptional Items
0.00
0.00
Consolidate Net Profit
4.37
27.21
-83.94%
Operating Profit Margin (Excl OI)
7.93%
22.43%
-14.50%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -25.44% vs 18.03% in Mar 2026

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2026 is -83.94% vs 213.48% in Mar 2026

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
202.88
206.81
-1.90%
Operating Profit (PBDIT) excl Other Income
12.90
25.27
-48.95%
Interest
0.61
0.75
-18.67%
Exceptional Items
-6.61
0.00
Consolidate Net Profit
-1.27
13.83
-109.18%
Operating Profit Margin (Excl OI)
6.36%
12.22%
-5.86%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -1.90% vs 15.21% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is -109.18% vs 62.32% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
324.18
308.26
5.16%
Operating Profit (PBDIT) excl Other Income
30.09
35.28
-14.71%
Interest
0.87
1.10
-20.91%
Exceptional Items
-8.53
0.00
Consolidate Net Profit
7.41
18.13
-59.13%
Operating Profit Margin (Excl OI)
9.28%
11.44%
-2.16%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 5.16% vs 10.41% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is -59.13% vs 27.14% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
467.34
438.49
6.58%
Operating Profit (PBDIT) excl Other Income
62.19
52.59
18.25%
Interest
1.13
1.55
-27.10%
Exceptional Items
-8.53
0.00
Consolidate Net Profit
34.61
26.80
29.14%
Operating Profit Margin (Excl OI)
13.31%
11.99%
1.32%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 6.58% vs 10.74% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 29.14% vs 13.75% in Mar 2025

stock-summaryCompany CV
About Borosil Scientific Ltd stock-summary
stock-summary
Borosil Scientific Ltd
Micro Cap
Industrial Products
Borosil Scientific Limited was originally incorporated as a Private Limited Company with the name and style of `Klass Pack Private Limited' and Certificate of Incorporation dated May 29, 1991 was issued by the Registrar of Companies, Mumbai).
Company Coordinates stock-summary
Icon
No Company Details Available